Pynegabine

派恩加滨

Report date: 2026/01/27 10:16:49
NME

Base Information

Drug NamePynegabine
Drug Alias NameHN-37
ClassificationNatural product/Extract
Mechanisms of ActionKCNQ (Kv7) potassium channel agonists
TargetsKCNQ (Kv7) potassium channel
Therapy Area/IndicationsSeizuresEpilepsyBronchitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesPharmaking
Active IndicationsSeizuresEpilepsy
Inactive IndicationsBronchitis

Other Information

ATC CodeN/A
Related LinksN/A